Skip to main content

Medical Education Nursing Contact Us

Home
Find a Doctor
Find a Location
Services
Patients and Visitors
MyChart Login

Search

Services

Spartanburg Regional Healthcare System is dedicated to providing patient-centered care to communities we serve. Explore the wide range of services we offer.

Frequently Visited Services

Behavioral Health
Breast Health
Cancer
Emergency
Heart

Hospice
Imaging
Immediate Care
Maternity
Pharmacy

Rehabilitation
Spine
Sports Medicine Institute
Telehealth
Weight Loss

Patients and Visitors

Whether you’re seeking care or visiting a loved one, Spartanburg Regional Healthcare System is here for you. Our compassionate team provides the resources and support you need so you can focus on what is important.

Patients

Advance Directives
Chaplain Services
ER Wait Times
Language Services
Medical Records
MyChart Help and Information
Patient Rights
Planning Discharge
Pre-admission Testing (PAT)
Recognize Your Caregiver
When to Go Where

Visitors

Directions & Maps
Gift Shops
Hotel Information
Visitor Guidelines
Volunteer
Wireless Internet

Financial

Bill Pay
Financial Assistance Program
Insurance Information
Pricing Policies
No Surprises Act

Find a Doctor
Find a Location
Services
Patients and Visitors
MyChart Login
Medical Education
Nursing
Contact Us

Search

Menu

Search

Clinical Research Trials

Search by Name

(-) Treatment
Clear all filters

Status

Accepting Participants
Closed

Disease Site

Breast Cancer
Symptom Management & Cancer Control
Gastrointestinal Cancer
Oncology
Thoracic Cancer
Cardiology
Genitourinary Cancer
Neurologic Cancer
Orthopaedic
Phase 1
Precision Medicine & Rare Tumors

Study Type

(-) Treatment
Observational

Oncology

Phase 1

Advanced Solid Tumors w/ FGF/FGFR Aberrations (TPU-TAS-120-101)
Closed

Breast Cancer

A Phase II Trial of Sacituzumab Govitecan (IMMU-132) (NSC #820016) for Patients With HER2-Negative Breast Cancer and Brain Metastases (S2007)
Accepting Participants
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (NSABP B-62 CAMBRIA-1)
Accepting Participants
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (NRG BR009)
Accepting Participants
Study of ORIC-114 in Patients with Advanced Solid Tumors Harboring an EGFR or HER2 Alteration (ORIC 114-01)
Accepting Participants
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (CCTG MA.39)
Accepting Participants

Gastrointestinal Cancer

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer (A022004)
Accepting Participants
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (NRG-GI008)
Accepting Participants

Thoracic Cancer

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study (S2302 Pragmatica)
Accepting Participants
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer (NRG-LU008)
Accepting Participants

Symptom Management & Cancer Control

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy (S2205)
Accepting Participants
High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients (URCC-22053 VIPER)
Accepting Participants
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy (WF-2201)
Accepting Participants
Multi-site Community Oncology Planning for the CONNECT Intervention Targeting Lung Cancer Caregivers (WF-2301CD)
Accepting Participants

Genitourinary Cancer

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer (NRG-GU013)
Accepting Participants

Other

Cardiology

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS (Dal-GenE-2 DAL-302)
Accepting Participants
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistula Study (VENO-CIP002 SAVE)
Accepting Participants

Orthopaedic

BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears (CSP-BB0003)
Accepting Participants

Oncology

A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients with Advanced Solid Tumors (LSTA1-P02 BOLSTER)
Accepting Participants

ABOUT US

Board of Trustees
Community Health
Diversity and Inclusion
Media Policy
Mission and Vision

News - Discover Health
Policies
Quality
Social Media Guidelines
Spartanburg Regional Healthcare System History
Spartanburg Regional Healthcare System Museum
The Spartanburg Community

RESOURCES

Careers
Employees
Price Transparency
Information for Vendors
Integrity Hotline

Medical Staff Services
Project SEARCH
Safety and Awareness
Sponsorship
Health Library
Transfer Center
Transportation Services
Volunteer

IMPORTANT LINKS

Apella Health Management
Discover Health
Regional HealthPlus
Southeastern Health Partners
Spartanburg Regional Foundation

© 2024 Spartanburg Regional Healthcare System. All Rights Reserved.